Kristina L. Conroy

FDA investigator

Appears on 10 documents from 2021 to 2023, mostly at sites in New Jersey. Most often cites production record review (21 CFR 211.192).

10
Documents on file
5.7
Observations per 483
2021
First seen
2023
Most recent

What they cite most

From 57 observations

Activity by year

2021: 2, 2022: 5, 2023: 3

Where

New Jersey 5 · Canada 1 · Maryland 1 · New York 1 · Pennsylvania 1 · Virginia 1

Is Kristina L. Conroy coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Contract Pharmaceuticals Limited CanadaNov 3, 2023 · Mississauga, Canada
483 AptaPharma Inc.May 15, 2023 · Pennsauken, New Jersey
483 Veranova, L.P.Feb 15, 2023 · West Deptford, New Jersey
483 Quotient Sciences - Philadelphia, LLCDec 22, 2022 · Boothwyn, Pennsylvania
483 CareFirst Specialty Pharmacy LLCNov 30, 2022 · Mount Laurel, New Jersey
483 Pharmaceutics International, Inc.Nov 14, 2022 · Cockeysville, Maryland
483 Wyeth Pharmaceutical Division of Wyeth Holdings LLCApr 13, 2022 · Pearl River, New York

About this profile

What does Kristina L. Conroy inspect?

Kristina L. Conroy appears on 10 documents on file covering 10 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.192 (production record review), followed by FDCA 501(a)(2)(A) and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kristina L. Conroy is dated Nov 3, 2023.